The ratio of ACAN-to-COL2A1 in BM-MSCs and AD-MSCs was higher in both GDF5 and GDF6 groups compared with either controls or TGF-β-treated cells, with no significant difference identified between the two cell types after stimulation with any of the growth factors (Figure 6C). Here, TGFB1 is linked to Alzheimer disease.